Yale Ventures accelerator funds — Blavatnik Fund for Innovation at Yale, Colton Center for Autoimmunity at Yale, Planetary Solutions Impact Accelerator, and Roberts Innovation Fund — provide crucial support in bridging early and translational research with the development of impactful technologies, startups, and industry partnerships.

Each year, these funds provide nearly $6 million in translational funding support, fueling faculty innovation at Yale. They have been critical to launching many of the 150+ Yale spinouts, helping turn world-class research into real-world solutions with financial support and mentorship from Yale staff and industry experts.

As part of a growing portfolio of academic innovation programming, these funds play a vital role in ensuring that groundbreaking ideas are not only advanced in the lab but also developed into technologies and ventures that positively impact people around the world.

If you are a Yale faculty or student innovator, I welcome you to explore our accelerator fund opportunities this year.

See you on campus,    

Josh Geballe

Managing Director, Yale Ventures

Senior Associate Provost for Entrepreneurship and Innovation at Yale University